179 related articles for article (PubMed ID: 8899107)
1. Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn's disease.
Zimmerman MJ; Jewell DP
Aliment Pharmacol Ther; 1996; 10 Suppl 2():93-8; discussion 99. PubMed ID: 8899107
[TBL] [Abstract][Full Text] [Related]
2. Maintenance therapy in ulcerative colitis and Crohn's disease.
Sachar DB
J Clin Gastroenterol; 1995 Mar; 20(2):117-22. PubMed ID: 7769190
[TBL] [Abstract][Full Text] [Related]
3. Controversies with aminosalicylates in inflammatory bowel disease.
Lim WC; Hanauer SB
Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
[TBL] [Abstract][Full Text] [Related]
4. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
Maier K; Fischer C; Klotz U; Heinkel K
Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1131-4. PubMed ID: 6123426
[TBL] [Abstract][Full Text] [Related]
5. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
Bonapace CR; Mays DA
Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055
[TBL] [Abstract][Full Text] [Related]
6. [Drug therapy of chronic inflammatory intestinal diseases].
Raedler A; Reinecker C
Immun Infekt; 1990 Aug; 18(4):121-6. PubMed ID: 2210794
[TBL] [Abstract][Full Text] [Related]
7. Maintenance drugs for inflammatory bowel disease.
Drug Ther Bull; 2001 Dec; 39(12):91-5. PubMed ID: 11799594
[TBL] [Abstract][Full Text] [Related]
8. Medical management of specific clinical presentations.
Bitton A; Peppercorn MA
Gastroenterol Clin North Am; 1995 Sep; 24(3):541-58. PubMed ID: 8809235
[TBL] [Abstract][Full Text] [Related]
9. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
Nakshabendi IM; Duncan A; Russell RI
Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343
[TBL] [Abstract][Full Text] [Related]
10. Aminosalicylates.
Campregher C; Gasche C
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):535-46. PubMed ID: 22122769
[TBL] [Abstract][Full Text] [Related]
11. [Long-term therapy in ulcerative colitis and Crohn's disease].
Malchow H
Fortschr Med; 1979 Aug; 97(29):1253-60. PubMed ID: 457018
[TBL] [Abstract][Full Text] [Related]
12. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
Feurle GE; Helmstädter V
Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
[No Abstract] [Full Text] [Related]
13. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
Moum B
Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
[TBL] [Abstract][Full Text] [Related]
14. [New therapeutic possibilities in chronic inflammatory bowel diseases].
Zeitz M
Praxis (Bern 1994); 1997 Jun; 86(25-26):1071-4. PubMed ID: 9289806
[TBL] [Abstract][Full Text] [Related]
15. How important is onset of action in ulcerative colitis therapy?
Masson S; Nylander D; Mansfield JC
Drugs; 2005; 65(15):2069-83. PubMed ID: 16225364
[TBL] [Abstract][Full Text] [Related]
16. [Crohn disease and ulcerative colitis--newer therapeutic approaches].
Ewe K
Z Gastroenterol; 1993 Feb; 31(2):151-5. PubMed ID: 8096666
[TBL] [Abstract][Full Text] [Related]
17. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
18. [Inflammatory bowel diseases].
Kruis W
Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S73-5. PubMed ID: 15368174
[No Abstract] [Full Text] [Related]
19. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases].
Hartmann F; Plauth M
Internist (Berl); 1990 Nov; 31(11):702-6. PubMed ID: 2289856
[No Abstract] [Full Text] [Related]
20. Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update.
Martin F
Dig Dis Sci; 1987 Dec; 32(12 Suppl):57S-63S. PubMed ID: 2891469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
